Related Experiment Video
Updated: Dec 29, 2025

09:41
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.0K
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple
Meghan Salcedo1, Nikoletta Lendvai1, Donna Mastey1
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Clinical Lymphoma, Myeloma & Leukemia
|February 1, 2020
Abstract
No abstract available in PubMed .
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
568
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.8K